Pfizer, Amgen among 22 strategic firms eyeing Hong Kong expansion: source
Story summarySixth batch under investment-attraction initiative to also feature Boehringer Ingelheim, Hengrui and HAYA, with DiDi and AutoFlight joining transport push
Read at South China Morning PostOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.